(Stroke. 2007;38:402.)
© 2007 American Heart Association, Inc.
Research Reports |
From the Department of Academic Neurosurgery, Addenbrookes Hospital, Cambridge, UK (A.L., E.A.S., C.H., P.S., J.D.P., M.C.); Institute of Anesthesiology and Intensive Care Medicine, University of Brescia, Brescia, Italy (A.L.); Department of Neurosurgery, Hopital Purpan, Toulouse, France (E.A.S.); and Department of Neurology, University Hospital Aachen, Aachen, Germany (C.H.).
Correspondence to Dr Marek Czosnyka, Academic Neurosurgery, Box 167, Addenbrookes Hospital, Cambridge, UK. E-mail Mc141{at}medschl.cam.ac.uk
| Abstract |
|---|
|
|
|---|
Methods The study included 10 head-injured adults. Intracranial pressure was monitored with a parenchymal probe. Arterial blood pressure was monitored simultaneously with an arterial catheter and with the Finapres plethysmograph. Flow velocity in the middle cerebral artery was measured bilaterally with transcranial Doppler. Mx and nMxa were computed in both hemispheres, and asymmetry of autoregulation was calculated.
Results Ninety-six measures of Mx and nMxa were obtained (48 for each side) in 10 patients. Mx correlated with nMxa (R=0.755, P<0.001; 95% agreement=±0.36; bias=0.01). Asymmetry in autoregulation assessed with Mx correlated significantly with asymmetry estimated with nMxa (R=0.857, P<0.0001; 95% agreement=±0.26; bias=0.03).
Conclusions The noninvasive index of autoregulation nMxa correlates with Mx and is sensitive enough to detect autoregulation asymmetry. nMxa is proposed as a practical tool to assess cerebral autoregulation in patients who do not require invasive monitoring.
Key Words: head injury neuromonitoring transcranial Doppler autoregulation cerebral blood flow
| Introduction |
|---|
|
|
|---|
Mx is used for continuous CA assessment in intensive care, where ABP and ICP are routinely monitored. However, there are several other clinical conditions in which assessment of Mx would be valuable, such as stroke, autonomic disorders, recurrent syncope, migraine, liver failure, and eclampsia. These conditions require a completely noninvasive approach to the study of CA.
CA can also be estimated noninvasively by calculating the correlation coefficient between slow changes of ABP, evaluated with the use of a finger plethysmograph (noninvasive ABP [nABP]), and slow changes of FV measured with transcranial Doppler. This index, termed nMxa, was used for evaluation of CA in patients suffering from carotid artery disease.3
To our knowledge, no study has compared nMxa in respect to the invasive index of autoregulation Mx. Therefore, we investigated the degree of agreement between those 2 indices describing CA.
| Methods |
|---|
|
|
|---|
ICP was monitored with Codman parenchymal probes (Johnson&Johnson Medical, Raynham, Mass).
ABP was monitored invasively (ABP) through an arterial line positioned in the radial artery and connected to a pressure transducer (Baxter, Healthcare Cardiovascular Group) zeroed at heart level.
ABP was monitored noninvasively (nABP) with a servo-controlled finger plethysmograph (Finapres2300, Ohmeda). The hand was kept steady at heart level.
CPP was calculated as the difference between ABP and ICP.
FV in both middle cerebral arteries was measured with transcranial Doppler (DWL-MultiDop, DWL). Two-megahertz probes were held in position by means of a purpose-built apparatus (LAM-Rack, DWL).
ICP, ABP, nABP, CPP, and FV were monitored simultaneously for a duration of 30 minutes daily. Monitoring of blood pressure and ICP and daily assessment of CA by transcranial Doppler are part of the clinical routine after severe head injury. The ethical committee was informed, and consents to publish recorded data were obtained.
ICP, ABP, nABP, CPP, and FV waveforms were captured digitally with a sampling rate of 50 Hz on bedside laptops running house-built software (ICM+). Artifacts were removed offline. Mx was calculated as the correlation coefficient between CPP mean and FV, and nMxa was calculated as the correlation coefficient between nABP mean and FV mean (Figure 1).
|
To assess whether the nMxa is sensitive enough to identify the left-right asymmetry of CA, we compared the left-right differences of the 2 indices of CA.
Using transfer function analysis, we evaluated whether the Finapres nABP accurately replicates ABP slow waves (0.01 to 0.15 Hz). If Finapres slow waves can be detected as reliably as with the invasive ABP measurement, the simultaneous monitoring should yield a sufficient linearity (coherence >0.4), and slow waves should have similar amplitude ratios (transfer function gains approaching unity).
Correlations between indices were expressed as Pearson R correlation indexes and probability values. Limits of agreement were calculated according to Bland and Altman.5
| Results |
|---|
|
|
|---|
The signal transmission from ABP to nABP in the low-frequency range was evaluated in terms of average coherence=0.90±0.08 and transfer function gain=1.33±0.93.
nMxa correlated positively with Mx (R=0.755, P<0.001; 95% agreement=±0.36; bias=0.01; Figure 2).
|
Asymmetry in autoregulation, calculated as nMxaleft nMxaright, correlated positively with asymmetry in CA assessed by MxleftMxright (R=0.857, P<0.0001; 95% agreement=±0.26; bias=0.03; Figure 3).
|
| Discussion |
|---|
|
|
|---|
The use of noninvasive nMxa implies 2 assumptions: (1) negligibility of ICP changes on CA calculation and (2) accuracy of Finapres ABP slow-wave estimation.
The assumption of considering the magnitude of ICP changes negligible in respect to CA assessment was verified in a previous report and confirmed by our results.6 We must, however, emphasize that CA evaluation does not substitute for ICP monitoring, the latter allowing recognition of intracranial hypertension and CPP management. Invasive Mx therefore should be considered the reference method for CA assessment in head-injured patients.
The assumption that Finapres nABP accurately replicates the slow waves of ABP was proven with transfer function analysis. Coherence and transfer function gain close to unity indicate that (1) the transmission from ABP to nABP is linear and (2) there is no significant dampening or amplification of the signal, respectively. The correct use of the Finapres device (adequate finger cuff size, hand kept steady at heart level) accurately replicates ABP slow waves, supporting the strong correlation between nMxa and Mx.
Noninvasive Mxa has been validated previously in healthy volunteers with the Aaslids cuff test used as a reference method.7 However, no previous study verified this noninvasive approach in direct comparison to the Mx.
The limits of agreement between Mx and nMxa are ±0.36. Although nMxa satisfactorily describes CA in comparison to Mx (R=0.755), the 2 indexes should not be used interchangeably.
Asymmetry in autoregulation suggests midline shift and is a predictor of fatal outcome after head injury.8 Autoregulation asymmetry may prompt brain imaging and allows optimization of CPP. To explore whether the noninvasive index could describe interhemispheric differences in CA, we plotted Mx(leftright) against nMxa(leftright). Good correlation (R=0.857) indicates that nMxa has an acceptable capability of detecting asymmetry in CA.
| Conclusion |
|---|
|
|
|---|
| Acknowledgments |
|---|
Sources of Funding
Drs Czosnyka and Smielewsi are supported by Medical Research Council grant G9439390, ID 65883. Dr Czosnyka is on unpaid leave from Warsaw University.
Disclosures
ICM+ software (www.neurosurg.cam.ac.uk/icmplus) is licensed by University of Cambridge, Cambridge, UK, and Drs Smielewski and Czosnyka have a financial interest in the fraction of licensing fee.
Received September 13, 2006; accepted October 3, 2006.
| References |
|---|
|
|
|---|
2. Lang EW, Mehdorn HM, Dorsch NW, Czosnyka M. Continuous monitoring of cerebrovascular autoregulation: a validation study. J Neurol Neurosurg Psychiatry. 2002; 72: 583586.
3. Reinhard M, Roth M, Guschlbauer B, Harloff A, Timmer J, Czosnyka M, Hetzel A. Dynamic cerebral autoregulation in acute ischemic stroke assessed from spontaneous blood pressure fluctuations. Stroke. 2005; 36: 16841689.
4. Menon DK. Cerebral protection in severe brain injury: physiological determinants of outcome and their optimisation. Br Med Bull. 1999; 55: 226258.
5. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999; 8: 135160.
6. Schmidt B, Czosnyka M, Raabe A, Yahya H, Schwarze JJ, Sackerer D, Sander D, Klingelhofer J. Adaptive noninvasive assessment of intracranial pressure and cerebral autoregulation. Stroke. 2003; 34: 8489.
7. Piechnik SK, Yang X, Czosnyka M, Smielewski P, Fletcher SH, Jones AL, Pickard JD. The continuous assessment of cerebrovascular reactivity: a validation of the method in healthy volunteers. Anesth Analg. 1999; 89: 944949.
8. Schmidt EA, Czosnyka M, Steiner LA, Balestreri M, Smielewski P, Piechnik SK, Matta BF, Pickard JD. Asymmetry of pressure autoregulation after traumatic brain injury. J Neurosurg. 2003; 99: 991998.[CrossRef][Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
J. K. Lee, K. K. Kibler, P. B. Benni, R. B. Easley, M. Czosnyka, P. Smielewski, R. C. Koehler, D. H. Shaffner, and K. M. Brady Cerebrovascular Reactivity Measured by Near-Infrared Spectroscopy Stroke, May 1, 2009; 40(5): 1820 - 1826. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |